Compile Data Set for Download or QSAR
Report error Found 70 Enz. Inhib. hit(s) with all data for entry = 50027934
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50255975((S)-2-cyclohexyl-2-(3-(3-(2,6-dichloro-4-(trifluor...)
Affinity DataIC50: 5nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256329(1-(3-(3-mesitylureido)-2-naphthamido)cyclooctaneca...)
Affinity DataIC50: 5nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50255977((S)-2-cyclohexyl-2-(3-(3-mesitylureido)-2-naphtham...)
Affinity DataIC50: 6nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256169((S)-2-cyclohexyl-2-(3-(3-mesitylureido)-2-naphtham...)
Affinity DataIC50: 10nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256071(2-(4,4-difluorocyclohexyl)-2-(3-(3-mesitylureido)-...)
Affinity DataIC50: 13nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256012((S)-2-cyclopentyl-2-(3-(3-mesitylureido)-2-naphtha...)
Affinity DataIC50: 14nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256330(1-(3-(3-mesitylureido)-2-naphthamido)cyclodecaneca...)
Affinity DataIC50: 14nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243599((S)-2-cyclohexyl-2-(2-(3-(2,6-dichlorophenyl)ureid...)
Affinity DataIC50: 21nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256393(2-(3-(3-mesitylureido)-2-naphthamido)-1,2,3,4-tetr...)
Affinity DataIC50: 27nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256328(1-(3-(3-mesitylureido)-2-naphthamido)cycloheptanec...)
Affinity DataIC50: 36nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256072((S)-2-((1r,4S)-4-methylcyclohexyl)-2-(3-(3-(2,4,6-...)
Affinity DataIC50: 56nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50255976((S)-2-cyclohexyl-2-(3-(3-(2,4,6-trichlorophenyl)ur...)
Affinity DataIC50: 65nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM27725((2S)-2-[(3-{[(2-chloro-6-methylphenyl)carbamoyl]am...)
Affinity DataIC50: 73nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256392(2-(3-(3-mesitylureido)-2-naphthamido)-2,3-dihydro-...)
Affinity DataIC50: 91nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256116(2-(3-(3-mesitylureido)-2-naphthamido)-2-(tetrahydr...)
Affinity DataIC50: 97nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256168(2-(3-(3-mesitylureido)-2-naphthamido)-2-(1,4-dioxa...)
Affinity DataIC50: 106nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243601((S)-2-cyclohexyl-2-(3-(3-(2,6-dimethylphenyl)ureid...)
Affinity DataIC50: 120nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256118((S)-2-(3-(3-mesitylureido)-2-naphthamido)-2-((S)-3...)
Affinity DataIC50: 132nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256072((S)-2-((1r,4S)-4-methylcyclohexyl)-2-(3-(3-(2,4,6-...)
Affinity DataIC50: 180nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256117(2-(3-(3-mesitylureido)-2-naphthamido)-2-(4-oxocycl...)
Affinity DataIC50: 199nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256073((S)-2-((1s,4R)-4-tert-butylcyclohexyl)-2-(3-(3-(2,...)
Affinity DataIC50: 210nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50255976((S)-2-cyclohexyl-2-(3-(3-(2,4,6-trichlorophenyl)ur...)
Affinity DataIC50: 224nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50255975((S)-2-cyclohexyl-2-(3-(3-(2,6-dichloro-4-(trifluor...)
Affinity DataIC50: 273nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256269(1-(3-(3-mesitylureido)-2-naphthamido)cyclopentanec...)
Affinity DataIC50: 279nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243599((S)-2-cyclohexyl-2-(2-(3-(2,6-dichlorophenyl)ureid...)
Affinity DataIC50: 320nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256012((S)-2-cyclopentyl-2-(3-(3-mesitylureido)-2-naphtha...)
Affinity DataIC50: 321nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256270(1-(3-(3-mesitylureido)-2-naphthamido)cyclohexaneca...)
Affinity DataIC50: 339nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256169((S)-2-cyclohexyl-2-(3-(3-mesitylureido)-2-naphtham...)
Affinity DataIC50: 350nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50255977((S)-2-cyclohexyl-2-(3-(3-mesitylureido)-2-naphtham...)
Affinity DataIC50: 373nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256330(1-(3-(3-mesitylureido)-2-naphthamido)cyclodecaneca...)
Affinity DataIC50: 443nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM27725((2S)-2-[(3-{[(2-chloro-6-methylphenyl)carbamoyl]am...)
Affinity DataIC50: 460nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in absence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256329(1-(3-(3-mesitylureido)-2-naphthamido)cyclooctaneca...)
Affinity DataIC50: 498nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256073((S)-2-((1s,4R)-4-tert-butylcyclohexyl)-2-(3-(3-(2,...)
Affinity DataIC50: 556nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256328(1-(3-(3-mesitylureido)-2-naphthamido)cycloheptanec...)
Affinity DataIC50: 585nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50255977((S)-2-cyclohexyl-2-(3-(3-mesitylureido)-2-naphtham...)
Affinity DataIC50: 610nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256071(2-(4,4-difluorocyclohexyl)-2-(3-(3-mesitylureido)-...)
Affinity DataIC50: 650nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256268(1-(3-(3-mesitylureido)-2-naphthamido)cyclopropanec...)
Affinity DataIC50: 720nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256267(2-(3-(3-mesitylureido)-2-naphthamido)-2-propylpent...)
Affinity DataIC50: 732nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256072((S)-2-((1r,4S)-4-methylcyclohexyl)-2-(3-(3-(2,4,6-...)
Affinity DataIC50: 845nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256391(1-(ethoxycarbonyl)-4-(3-(3-mesitylureido)-2-naphth...)
Affinity DataIC50: 970nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM27725((2S)-2-[(3-{[(2-chloro-6-methylphenyl)carbamoyl]am...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256071(2-(4,4-difluorocyclohexyl)-2-(3-(3-mesitylureido)-...)
Affinity DataIC50: 1.01E+3nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243601((S)-2-cyclohexyl-2-(3-(3-(2,6-dimethylphenyl)ureid...)
Affinity DataIC50: 1.06E+3nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256393(2-(3-(3-mesitylureido)-2-naphthamido)-1,2,3,4-tetr...)
Affinity DataIC50: 1.07E+3nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256331(1-(3-(3-mesitylureido)-2-naphthamido)-4-oxocyclohe...)
Affinity DataIC50: 1.15E+3nMAssay Description:Inhibition of human liver glycogen phosphorylase A by fluorescence intensity endpoint assay in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256012((S)-2-cyclopentyl-2-(3-(3-mesitylureido)-2-naphtha...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM27725((2S)-2-[(3-{[(2-chloro-6-methylphenyl)carbamoyl]am...)
Affinity DataIC50: 1.29E+3nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256270(1-(3-(3-mesitylureido)-2-naphthamido)cyclohexaneca...)
Affinity DataIC50: 1.39E+3nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256269(1-(3-(3-mesitylureido)-2-naphthamido)cyclopentanec...)
Affinity DataIC50: 1.77E+3nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50256168(2-(3-(3-mesitylureido)-2-naphthamido)-2-(1,4-dioxa...)
Affinity DataIC50: 2.05E+3nMAssay Description:Inhibition of human liver glycogen phosphorylase A in HepG2 cells assessed as forskolin-induced glycogenolysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
Displayed 1 to 50 (of 70 total ) | Next | Last >>
Jump to: